Loading...

GERN GERON CORP US FDA Inspections 8-K Filing

GRN

GRN

GERON CORP

(GERN)

2024 8-K

Show Summary

Show Summary

Management Changes

Financial Statements

Management Change

Management Changes

Financial Results

Earnings Guidance

Funding Agreements

Earnings Reports

FDA Approval for RYTELOTM

Annual Meeting of Stockholders

Earnings Report

Underwriting Agreement

Results of FDA Advisory Com...

Results of Operations and F...

Financial Condition

Amendment and Restatement o...

Appointment of New Director

Entry into a Material Defin...

Appointment of CFO

Earnings Report

Annual Meeting and Amendments

Earnings Reports

Conference Participation

External Links:

Geron Corp announced FDA approval of RYTELOTM for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes (MDS) with transfusion-dependent (TD) anemia.

AI Assistant

GERON CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.